Overview
The Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 is a technical update to the official list of ingredients allowed in therapeutic goods (medicines) in Australia. It is made under the Therapeutic Goods Act 1989 and administered by the Department of Health, Disability and Ageing.
Period Covered
The version of the instrument shown covers the period 17 September 2026 to 15 October 2026. The instrument is listed as in force, though the record also shows it has since been repealed and replaced by a later version.
The source page does not specify which ingredients were added, removed, or changed, nor does it name any specific products or companies affected.
Who This Concerns
This mainly concerns manufacturers, importers, and suppliers of medicines and therapeutic goods who need to check their products against the current permissible ingredients list and label warning statement requirements.
Key Actions
- If manufacturing, importing, or selling medicines or therapeutic goods, check the current Schedule 1 list of permissible ingredients on the Federal Register of Legislation page to confirm products comply
- Review clause 6A on warning statement requirements for labels against current product labelling
- Use the 'Set up an alert' or 'Save this title to My Account' features on the register page to be notified of future versions or repeals affecting this determination
- Check with the Department of Health, Disability and Ageing or the Therapeutic Goods Administration if unsure whether a specific ingredient in a product is still permissible
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.